N. Sichtig

Short communication: selection of thymidine analogue resistance mutational patterns in children infected from a common HIV type 1 subtype G source.

Thomas Lengauer, R. Kaiser, K. Roomp, 2010, AIDS research and human retroviruses.

Papillomavirus binding factor binds to SAP30 and represses transcription via recruitment of the HDAC1 co-repressor complex.

G. Steger, N. Sichtig, Nadine Körfer, 2007, Archives of biochemistry and biophysics.

Performance of Genotypic Coreceptor Measurement Using Geno2pheno[coreceptor] in B- and non-B HIV Subtypes in a Large Cohort of Therapy-experienced Patients in Germany

Thomas Lengauer, H. Walter, R. Kaiser, 2009 .

Improved Genotypic Prediction of HIV-1 Coreceptor Usage by Incorporating V2 Loop Sequence Variation

Thomas Lengauer, Rolf Kaiser, Andrew Moores, 2008 .

Determination of HIV-1 co-receptor usage in German patients – comparison of genotypic methods with the TROFILE® phenotypic assay

H. Walter, R. Kaiser, T. Berg, 2008 .

Papillomavirus binding factor (PBF)-mediated inhibition of cell growth is regulated by 14-3-3beta.

G. Steger, S. Silling, N. Sichtig, 2007, Archives of biochemistry and biophysics.

Changes in the HIV‐1 mutational profile before first‐line HAART in the RESINA cohort

R. Kaiser, D. Häussinger, B. Jensen, 2011, Journal of medical virology.

Improved prediction of HIV‐1 coreceptor usage with sequence information from the second hypervariable loop of gp120.

Thomas Lengauer, Rolf Kaiser, Alexander Thielen, 2010, The Journal of infectious diseases.

Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naïve patients.

K. Metzner, H. Walter, R. Kaiser, 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Evolution of raltegravir resistance during therapy.

R. Kaiser, A. Altmann, M. Däumer, 2009, The Journal of antimicrobial chemotherapy.